Literature DB >> 26746779

Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9.

Voraluck Phatarakijnirund1, Steven Mumm2, William H McAlister3, Deborah V Novack4, Deborah Wenkert5, Karen L Clements6, Michael P Whyte7.   

Abstract

Congenital insensitivity to pain (CIP) comprises the rare heritable disorders without peripheral neuropathy that feature inability to feel pain. Fracturing and joint destruction are common complications, but lack detailed studies of mineral and skeletal homeostasis and bone histology. In 2013, discovery of a heterozygous gain-of-function mutation in SCN11A encoding voltage-gated sodium channel 1.9 (Nav1.9) established a distinctive CIP in three unrelated patients who suffered multiple painless fractures, self-inflicted mutilation, chronic diarrhea, and hyperhidrosis. Here, we studied a mother and two children with CIP by physical examination, biochemical testing, radiological imaging including DXA, iliac crest histology, and mutation analysis. She suffered fractures primarily of her lower extremities beginning at age two years, and had Charcot deformity of both ankles and joint hypermobility. Nerve conduction velocity together with electromyography were normal. Her children had recurrent major fractures beginning in early childhood, joint hypermobility, and chronic diarrhea. She had an excoriated external nare, and both children had hypertrophic scars from scratching. Skin collagen studies were normal. Radiographs revealed fractures and deformities. However, lumbar spine and total hip BMD Z-scores, biochemical parameters of mineral and skeletal homeostasis, and iliac crest histology of the mother (after in vivo tetracycline labeling) were normal. Genomic DNA from the children revealed a unique heterozygous missense mutation in exon 23 (c.3904C>T, p.Leu1302Phe) of SCN11A that is absent in SNP databases and alters an evolutionarily conserved amino acid. This autosomal dominant CIP reflects the second gain-of-function mutation of SCN11A. Perhaps joint hypermobility is an unreported feature. How mutation of Nav1.9 causes fracturing remains unexplained. Lack of injury awareness is typically offered as the reason, and was supported by our unremarkable biochemical, radiological, and histological findings indicating no skeletal pathobiology. However, low-trauma fracturing in these patients suggests an uncharacterized defect in bone quality.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Charcot arthropathy; Joint hypermobility; Mineral homeostasis; Skeletal homeostasis

Mesh:

Substances:

Year:  2015        PMID: 26746779      PMCID: PMC4755825          DOI: 10.1016/j.bone.2015.11.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  54 in total

1.  Hereditary insensitivity to pain.

Authors:  F R ERVIN; R A STERNBACH
Journal:  Trans Am Neurol Assoc       Date:  1960

2.  Dominantly transmitted congenital indifference to pain.

Authors:  P Landrieu; G Said; C Allaire
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

3.  Congenital universal indifference to pain.

Authors:  D A BOYD; L W NIE
Journal:  Arch Neurol Psychiatry       Date:  1949-04

Review 4.  Genotype phenotype associations across the voltage-gated sodium channel family.

Authors:  Andreas Brunklaus; Rachael Ellis; Eleanor Reavey; Christopher Semsarian; Sameer M Zuberi
Journal:  J Med Genet       Date:  2014-08-27       Impact factor: 6.318

5.  Congenital insensitivity to pain. Orthopaedic manifestations.

Authors:  E Bar-On; D Weigl; R Parvari; K Katz; R Weitz; T Steinberg
Journal:  J Bone Joint Surg Br       Date:  2002-03

6.  Congenital absence of pain.

Authors:  M Manfredi; G Bini; G Cruccu; N Accornero; A Berardelli; L Medolago
Journal:  Arch Neurol       Date:  1981-08

7.  Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.

Authors:  Jianying Huang; Yang Yang; Peng Zhao; Monique M Gerrits; Janneke G J Hoeijmakers; Kim Bekelaar; Ingemar S J Merkies; Catharina G Faber; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

8.  Congenital insensitivity to pain in a child attending a paediatric fracture clinic.

Authors:  Mohamed Abdulla; Sari S Khaled; Yazan S Khaled; Harish Kapoor
Journal:  J Pediatr Orthop B       Date:  2014-09       Impact factor: 1.041

9.  No pain, more gain.

Authors:  James J Cox; John N Wood
Journal:  Nat Genet       Date:  2013-11       Impact factor: 38.330

Review 10.  Structure of the sodium channel gene SCN11A: evidence for intron-to-exon conversion model and implications for gene evolution.

Authors:  Sulayman D Dib-Hajj; Lynda Tyrrell; Stephen G Waxman
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

View more
  21 in total

Review 1.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

2.  [Pain and analgesia : Mutations of voltage-gated sodium channels].

Authors:  M J Eberhardt; A Leffler
Journal:  Schmerz       Date:  2017-02       Impact factor: 1.107

3.  Pain insensitivity: distal S6-segment mutations in NaV1.9 emerge as critical hotspot.

Authors:  Margaret K King; Enrico Leipold; Jessica M Goehringer; Ingo Kurth; Thomas D Challman
Journal:  Neurogenetics       Date:  2017-03-13       Impact factor: 2.660

4.  Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability.

Authors:  Jianying Huang; Carlos G Vanoye; Alison Cutts; Y Paul Goldberg; Sulayman D Dib-Hajj; Charles J Cohen; Stephen G Waxman; Alfred L George
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

Review 5.  Sodium channels in pain disorders: pathophysiology and prospects for treatment.

Authors:  Sulayman D Dib-Hajj; Paul Geha; Stephen G Waxman
Journal:  Pain       Date:  2017-04       Impact factor: 6.961

Review 6.  Genetic pain loss disorders.

Authors:  Annette Lischka; Petra Lassuthova; Arman Çakar; Christopher J Record; Jonas Van Lent; Jonathan Baets; Maike F Dohrn; Jan Senderek; Angelika Lampert; David L Bennett; John N Wood; Vincent Timmerman; Thorsten Hornemann; Michaela Auer-Grumbach; Yesim Parman; Christian A Hübner; Miriam Elbracht; Katja Eggermann; C Geoffrey Woods; James J Cox; Mary M Reilly; Ingo Kurth
Journal:  Nat Rev Dis Primers       Date:  2022-06-16       Impact factor: 65.038

7.  Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta.

Authors:  Jose A Caparros-Martin; Mona S Aglan; Samia Temtamy; Ghada A Otaify; Maria Valencia; Julián Nevado; Elena Vallespin; Angela Del Pozo; Carmen Prior de Castro; Lucia Calatrava-Ferreras; Pilar Gutierrez; Ana M Bueno; Belen Sagastizabal; Encarna Guillen-Navarro; Maria Ballesta-Martinez; Vanesa Gonzalez; Sarenur Y Basaran; Ruksan Buyukoglan; Bilge Sarikepe; Cecilia Espinoza-Valdez; Francisco Cammarata-Scalisi; Victor Martinez-Glez; Karen E Heath; Pablo Lapunzina; Victor L Ruiz-Perez
Journal:  Mol Genet Genomic Med       Date:  2016-12-20       Impact factor: 2.183

8.  Electrophysiological and Pharmacological Analyses of Nav1.9 Voltage-Gated Sodium Channel by Establishing a Heterologous Expression System.

Authors:  Xi Zhou; Zhen Xiao; Yan Xu; Yunxiao Zhang; Dongfang Tang; Xinzhou Wu; Cheng Tang; Minzhi Chen; Xiaoliu Shi; Ping Chen; Songping Liang; Zhonghua Liu
Journal:  Front Pharmacol       Date:  2017-11-22       Impact factor: 5.810

9.  Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Nav1.7 mutation that massively hyperpolarizes activation.

Authors:  Jianying Huang; Malgorzata A Mis; Brian Tanaka; Talia Adi; Mark Estacion; Shujun Liu; Suellen Walker; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

Review 10.  Genetic studies of human neuropathic pain conditions: a review.

Authors:  Katerina Zorina-Lichtenwalter; Marc Parisien; Luda Diatchenko
Journal:  Pain       Date:  2018-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.